Immunosuppressive effects of factor IX products: An in vitro study.

被引:0
|
作者
Grosset, AB
McGregor, JR
Samlowski, WE
Rodgers, GM
机构
[1] UNIV UTAH,SALT LAKE CITY,UT
[2] VET AFFAIRS MED CTR,SALT LAKE CITY,UT 84148
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1298 / 1298
页数:1
相关论文
共 50 条
  • [1] Immunosuppressive effects of factor IX products:: an in vitro study
    Grosset, AB
    McGregor, JR
    Samlowski, WE
    Rodgers, GM
    HAEMOPHILIA, 1999, 5 (06) : 416 - 425
  • [2] Immunosuppressive Effects of Emodin: An In Vivo and In Vitro Study
    Liu, Y. -X.
    Shen, N. -Y.
    Liu, C.
    Lv, Y.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1837 - 1839
  • [3] Modified factor VIII and factor IX recombinant products
    Santagostino, Elena
    Mancuso, Maria Elisa
    HEMASPHERE, 2018, 2 : 185 - 187
  • [4] IMMUNOSUPPRESSIVE TREATMENT IN HEMOPHILIACS WITH INHIBITORS TO FACTOR-VIII AND FACTOR-IX
    NILSSON, IM
    HEDNER, U
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1976, 16 (05): : 369 - 382
  • [5] Monitoring of modified factor VIII and IX products
    Kitchen, S.
    Gray, E.
    Mertens, K.
    HAEMOPHILIA, 2014, 20 : 36 - 42
  • [6] Androgen receptor effects on factor IX expression: In vitro and in vivo studies in mice
    Brady, JN
    Notley, C
    Lillicrap, D
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2338 - P2338
  • [7] USE OF FACTOR-VIII AND FACTOR-IX PRODUCTS
    BRITTEN, AFH
    VOX SANGUINIS, 1984, 46 : 12 - 14
  • [8] Successful second ITI with factor IX and combined immunosuppressive therapy A patient with severe haemophilia B and recurrence of a factor IX inhibitor
    Holstein, K.
    Schneppenheim, R.
    Schrum, J.
    Bokemeyer, C.
    Langer, F.
    HAMOSTASEOLOGIE, 2014, 34 (4A): : S5 - S8
  • [9] IMMUNOSUPPRESSIVE EFFECTS OF BACTERIAL EXTRACELLULAR PRODUCTS
    QUAGLIATA, F
    TARANTA, A
    FEDERATION PROCEEDINGS, 1973, 32 (MAR) : 1029 - +
  • [10] Factor IX and combined immunosuppressive therapy for successful second ITI in a patient with severe hemophilia B and recurrence of a factor IX-inhibitor
    Holstein, K.
    Schneppenheim, R.
    Schrum, J.
    Bokemeyer, C.
    Langer, F.
    HAEMOPHILIA, 2014, 20 : 71 - 72